(Q33162588)

English

Clinical safety, tolerance, and plasma levels of the oral anticholinesterase 1,2,3,4-tetrahydro-9-aminoacridin-1-oL-maleate (HP 029) in Alzheimer's disease: preliminary findings

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 July 2017

Clinical safety, tolerance, and plasma levels of the oral anticholinesterase 1,2,3,4-tetrahydro-9-aminoacridin-1-oL-maleate (HP 029) in Alzheimer's disease: preliminary findings (English)

1 reference

Europe PubMed Central

23 July 2017

Alzheimer's disease

0 references

author name string

Cutler NR

1

1 reference

Europe PubMed Central

23 July 2017

Murphy MF

2

1 reference

Europe PubMed Central

23 July 2017

Nash RJ

3

1 reference

Europe PubMed Central

23 July 2017

Prior PL

4

1 reference

Europe PubMed Central

23 July 2017

De Luna DM

5

1 reference

Europe PubMed Central

23 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 June 1990

1 reference

Europe PubMed Central

23 July 2017

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

23 July 2017

30

1 reference

Europe PubMed Central

23 July 2017

556-561

1 reference

Europe PubMed Central

23 July 2017

6

1 reference

Europe PubMed Central

23 July 2017

Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03620.X

21 January 2018

Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls. A dose-response study

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03620.X

21 January 2018

Scopolamine and the control of attention in humans.

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03620.X

21 January 2018

Single dose safety, tolerance, and pharmacokinetics of HP 029 in healthy young men: a potential Alzheimer agent

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03620.X

21 January 2018

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03620.X

21 January 2018

“Mini-mental state”

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03620.X

21 January 2018

The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03620.X

21 January 2018

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03620.X

21 January 2018

Physostigmine and arecoline: effects of intravenous infusions in Alzheimer presenile dementia

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1990.TB03620.X

21 January 2018

Identifiers

10.1002/J.1552-4604.1990.TB03620.X

1 reference

Europe PubMed Central

23 July 2017

1 reference

Europe PubMed Central

23 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33162588&oldid=1606320972"